[2026 Outlook] Pharma/BiotechIdentifying Leaders Within an Outperforming Sector
In 1H25, US policy uncertainty—i.e., potential drug tariffs, the most-favored-nation (MFN) pricing proposal, and Inflation Reduction Act (IRA) drug...
358 Views
Quam Morning Note (25 Sep) - InnoCare
InnoCare (9969 HK, NR) announces that InnoCare has entered into a strategic research collaboration and license agreement with Eli Lilly (LLY US,...
95 Views
KTX Tactical DR / DRX Picks
We recommend taking profit on LLY80X and TSLA80X, with investment returns of +18.0% and +18.3%, respectively, as they have exceeded the target...
91 Views
KTX Tactical DR / DRX Picks
The DR/DRx Portfolio invests in LLY80X, a reference instrument for ELI LILLY & CO on the US stock market. The prices of the underlying stocks...
88 Views